Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CE mark supreme, says UK's ABHI (Association of British Health-Care Industries):

This article was originally published in Clinica

Executive Summary

A new UK quality mark, British Made for Quality (BMfQ), is due to be unveiled next month as part of a new campaign to promote UK-manufactured goods for both the domestic and export markets. For the British medical devices industry, however, the "CE mark is the only mark we need to guarantee safety, quality and performance", Gordon Aylward, director-general of the Association of British Health-Care Industries (ABHI), told Clinica. The ABHI does not encourage the introduction of additional quality marks, he said, adding that there has been "quite a campaign to avoid other marks appearing".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel